About Us


Wuhan National Human Genetic Resources Biobank (hereinafter referred to as the "Biobank") As a key "Life and Health Industry Innovation Platform" jointly established by Hubei Province, Wuhan City, and the East Lake High-tech Development Zone, the Biobank is a comprehensive, application-oriented human genetic resources repository. It is dedicated to leveraging multi-channel, multi-category samples and large-scale multi-modal data to promote open sharing and clinical translation. Adhering to the principles of "no raw samples leaving the repository, no raw data leaving the domain, data availability without visibility.

Learn more +
Sample preservation capability

Sample storage capacity

15000000 copies
Data computing capability

Data storage capacity

30 PB
Computing power

Computing power

301 Trillion times/second

News


New Year's Day | Wuhan sample library is recognized as a high-tech enterprise

According to the relevant provisions of the Administrative Measures for the Identification of High-tech Enterprises (GKFH [2016] No. 32) and the Guidelines for the Identification and Management of High-tech Enterprises (GKFH [2016] No. 195), the National Leading Community Office for the Identification and Management of High-tech Enterprises issued the "Notice on the Filing and Publicity of the Fifth Batch of High-tech Enterprises Identified by the Hubei Provincial Accreditation Agency in 2022", Wuhan Biological Sample Bank Co., Ltd. (hereinafter referred to as "Wuhan Sample Bank") is recognized as a high-tech enterprise. High-tech enterprises refer to resident enterprises that have been registered in China (excluding Hong Kong, Macao and Taiwan) for more than one year by continuously carrying out research and development and transformation of technological achievements, forming core independent intellectual property rights of enterprises, and carrying out business activities on this basis within the "High-tech Fields Supported by the State". It is a knowledge-intensive and technology-intensive economic entity. In the future, Wuhan sample bank will further promote the conservation and utilization of human genetic resources and the transformation of achievements, and promote the innovation of biotechnology sources, so that Wuhan sample bank will become a "national" brand platform with strong "hematopoietic" ability, and help the high-quality development of the big health industry.

2023-01-13

Good news | Wuhan sample library won two qualification evaluations!

1、 Wuhan sample library was approved by Wuhan Enterprise R&D Center On November 11, 2022, Wuhan Municipal Bureau of Science and Technology issued the Notice on Publishing the First Batch of Wuhan Enterprise Research and Development Center Filing List in 2022 (WK [2022] No. 98), and the enterprise research and development center of Wuhan Biological Sample Bank Co., Ltd. was recognized at the municipal level. Wuhan Enterprise Research and Development Center (hereinafter referred to as "R&D Center") is a relatively independent scientific and technological research and development specialized organization established within the enterprise, mainly engaged in the research and development of new technologies, new products, new processes and new materials, and promoting the industrialization and application of scientific and technological achievements. Wuhan Biological Sample Library will effectively strengthen the construction and management of the research and development center, give full play to the supporting role of the research and development center in improving the technological innovation ability, and make positive contributions to the economic and social development of Wuhan. 2、 Wuhan sample library won the recognition of "Optics Valley Gazelle" enterprise in 2022 On November 4, 2022, the Science and Technology Innovation Bureau of Wuhan East Lake High-tech Zone issued the Notice on Publicizing the List of Enterprises to Be Identified as "Optics Valley Gazelle" in 2022, and Wuhan Biological Sample Library was successfully listed. "Gazelle enterprises" refer to small and medium-sized enterprises that have crossed the Death Valley and entered a high growth period with the support of technological innovation or business model innovation. The scope of identification is mainly that the industrial field conforms to the development direction of national and provincial strategic emerging industries, covering emerging industries, new generation information technology, biological health, artificial intelligence, financial technology, energy conservation and environmental protection, consumption upgrading and other fields, also known as "high growth enterprises". Such enterprises have the characteristics of "specialized, refined, special and new". The growth rate, scientific and technological content and industrial prospects are the three core indicators for the selection of "Gazelle Enterprises". In the future, Wuhan sample library will "base itself on Hubei, radiate the central region, and look around the world", and contribute to accelerating the research and development of innovative drugs, promoting the development of translational medicine, and leading the industrial transformation and upgrading.

2022-11-18

The First Symposium on Biosafety Informatics was grandly opened

On September 22, 2022, the "First Symposium on Biosafety Informatics", sponsored by the Chinese Society of Bioinformatics (preparatory), the Chinese Society of Biotechnology, the Wuhan Institute of Biotechnology, and the Hubei Society of Bioinformatics, hosted by Wuhan Biological Sample Bank Co., Ltd., and co-organized by the Wuhan East Lake National Independent Innovation Demonstration Zone Biomedical Industry Association, was grandly opened in the Wuhan National Human Genetic Resources Library. The opening ceremony of the conference was presided over by Zhang Hanrui, General Manager of Wuhan Biological Sample Bank Co., Ltd., Wang Songlie, Executive Vice President of Wuhan Institute of Biotechnology, and Zhang Hongyu, Dean of Information College of Huazhong Agricultural University and President of Hubei Bioinformatics Society, attended the opening ceremony and delivered a speech. General Manager Zhang Hanrui presided over the meeting Wang Songlie, Executive Vice President, delivered a speech President Zhang Hongyu delivers a speech With the theme of "Biosafety Informatics", the conference, centering on biosafety and high-performance computing, cutting-edge bioinformatics, the safe sharing and utilization of biological sample resources in the era of big data, biosafety and genomics big data, medical biosafety and bioinformatics and other professional directions, invited experts from the Medical Department of Peking University, Wuhan University, Huazhong University of Science and Technology, Harbin Medical University, Guangzhou National Laboratory Experts from Wuhan Institute of Virology, Chinese Academy of Sciences, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences and other units carried out in-depth exchanges to explore opportunities for cooperation. In the warm applause at the scene, the first biosafety informatics seminar officially kicked off, and the follow-up will present you with wonderful reports.

2022-09-22


Partner


Hubei University of Technology
Hubei Second Normal University
Hubei Provincial People's Hospital
Wuhan Botanical Garden, Chinese Academy of Sciences
Wuhan Institute of Virology, Chinese Academy of Sciences
Institute of Hydrobiology, Chinese Academy of Sciences
Lu General Hospital
Cancer Hospital
Hubei Provincial Hospital of Traditional Chinese Medicine
Xiangya Hospital
Wuhan Union Hospital
Wuhan University School of Stomatology